Occupational Stress or Workplace StressMBCRCTNCT07560371
Evaluating a Mindfulness Booster Course for Healthcare Staff
A study testing Mindfulness Booster Course in people with Occupational Stress or Workplace Stress, run by Canterbury Christ Church University at 1 site in United Kingdom.
Trial summary
The goal of this clinical trial is to learn if a mindfulness booster course can reduce stress in healthcare staff who have previously attended a mindfulness course. The main questions it aims to answer are: Is a mindfulness booster course for healthcare staff effective at reducing their stress levels? Are any benefits… Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Occupational Stress or Workplace Stress
- What is being tested?
- Mindfulness Booster Course
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 186 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- 13 May 2026to May 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- UK National Health Service staff member.
- Has completed an 8-week mindfulness course (either MBCT, MBCT-L or MBSR). Individuals will be considered to have "completed" a mindfulness course if they attended four or more sessions.
- Is able to make one of the planned sets of times for the booster course sessions, in case they are randomly allocated to the intervention arm.
Who cannot join
- Currently on sick leave.
- Planning on undertaking another 8-week mindfulness course.
- Previously participated in the mindfulness booster course in the feasibility study.
- Have previously found practising mindfulness distressing.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United Kingdom1 site
Sussex Mindfulness Centre
Worthing, West Sussex, BN11 1HS
About this study
Official title: A Randomized Controlled Trial of an 8-Week Mindfulness "Booster" Course for Staff: Examining Effectiveness, Mediators of Impact, and Participant Experiences
The goal of this clinical trial is to learn if a mindfulness booster course can reduce stress in healthcare staff who have previously attended a mindfulness course. The main questions it aims to answer are:
- Is a mindfulness booster course for healthcare staff effective at reducing their stress levels?
- Are any benefits maintained for 8 weeks?
Researchers will compare a mindfulness booster course with usual care to see if it helps to reduce stress. Participants will take part in either a mindfulness booster course or do what they usually do to look after their wellbeing. They will complete questionnaires at the beginning, middle and end of the study.
Read the detailed description
Aims:
- To determine whether the mindfulness booster course for healthcare staff is effective in terms of the primary outcome (perceived stress) and secondary outcomes (wellbeing, depression, burnout, and compassion for others), and whether any benefits are maintained at follow-up.
- To examine whether any effects on the above-mentioned outcomes are statistically mediated by changes in amount of mindfulness practice, rumination and worry, decentering, self-compassion, and trait mindfulness.
- To develop an abbreviated grounded theory of the therapeutic process and outcomes of the mindfulness booster course.
Hypotheses:
- a) The primary hypothesis is that we will see a significantly greater decrease in the primary outcome of perceived stress at post-intervention (the primary time-point of Weeks 11-12) relative to baseline (Weeks 0-1) for the 'mindfulness-booster course plus treatment as usual (TAU)' intervention group compared to the 'TAU-only' control group.
- Our secondary hypothesis is that we will see significantly greater improvements in each of our secondary outcome measures at post-intervention (Weeks 11-12) relative to baseline for our intervention group compared to our control group. Improvements entail decreases in depression and burnout and increases in compassion for others and wellbeing.
- Our third hypothesis is that we will also see the effects detailed in (1a) and (1b) above at the follow-up time-point (Weeks 19-20).
- a) The relationship between group allocation (intervention vs. control) and reduction in perceived stress, from baseline to follow-up (Weeks 19-20), will be statistically mediated by changes from baseline to post-intervention in the following psychological constructs: i) increase in amount of mindfulness practice, both formal and informal; ii) reduction in rumination and worry, i.e., repetitive negative thinking; iii) increase in decentering; iv) increase in self-compassion; v) increase in trait mindfulness.
- The relationships specified in Hypothesis 2a will also hold true for the secondary outcomes (i.e. change from baseline to follow-up [Weeks 19-20] in wellbeing, depression, burnout and compassion for others).
- i) The relationship between group allocation and reduction in perceived stress will be serially statistically as follows: intervention group allocation predicts increased mindfulness practice (from baseline to post-intervention [Weeks 11-12]) which in turn predicts change in psychological mechanisms (i.e., rumination/worry, decentering, self-compassion and trait mindfulness; from baseline to post-intervention [Weeks 11-12]), which in turn predict reduced perceived stress (from baseline to follow-up [Weeks 19-20]). ii) The relationships specified in Hypothesis 2c-i will also hold for the secondary outcomes (i.e. change from baseline to follow-up [Weeks 19-20] in wellbeing, depression, burnout and compassion for others). Design Information Not Included Elsewhere in this Registration: After Weeks 11-12, a subsample of intervention group participants will be invited to participate in a semi-structured individual interview, with the qualitative data being collected and analysed according to grounded theory principles. This aspect of the study has the following sub-aims:
- To explore what processes occur during the mindfulness booster course, based on participants' experiences.
- To explore how these processes interact with the participants' contexts, including, but not limited to, working in healthcare.
- To explore how these processes and contexts interact with, and perhaps drive, any perceived impacts and outcomes of the course.
- Conditions
- Occupational Stress or Workplace Stress
- Being tested
- Mindfulness Booster Course, Usual Care
- Keywords
- booster course, mindfulness, health personnel, perceived stress, health care workers
- Medical subject headings
- Occupational Stress
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Mindfulness Booster CourseBehavioural
The mindfulness booster course will consist of eight 30-minute sessions, which participants will be asked to commit to. These will be online and usually occur weekly. Within these sessions, there will be a 15-minute mindfulness practice followed by a 15-minute discussion. This discussion time will involve reflecting on the mindfulness practice and speaking about between-session practice. Participants will be encouraged to practice mindfulness for home work between the sessions.
Usual CareBehavioural
Participants will be encouraged to continue with whatever activities they usually undertake to manage their stress and support their wellbeing.
| Study group | Role | What they receive |
|---|---|---|
| Mindfulness Booster Course | Experimental | Not described Receives: Behavioral: Mindfulness Booster Course; Behavioral: Usual Care |
| Treatment as usual control | Other | Not described Receives: Behavioral: Usual Care |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Perceived Stress Scale score from baseline (Weeks 0-1) at Weeks 11-12.
The 10-item Perceived Stress Scale (PSS-10) is a self-report measure of perceived stress, which produces a score ranging between 0 and 40. A higher score indicates greater perceived stress.
Measured: Baseline (Weeks 0-1) and Weeks 11-12
Secondary outcomes (9)
Change in Perceived Stress Scale score from baseline (Weeks 0-1) at Weeks 19-20.
The 10-item Perceived Stress Scale (PSS-10) is a self-report measure of perceived stress, which produces a score ranging between 0 and 40. A higher score indicates greater perceived stress.
Measured: Baseline (Weeks 0-1) and Weeks 19-20
Change in 8-item Patient Health Questionnaire score from baseline (Weeks 0-1) at Weeks 11-12.
The 8-item Patient Health Questionnaire (PHQ-8) is a self-report measure of depression, which produces a score ranging between 0 and 24. A higher score indicates a greater level of depression symptoms.
Measured: Baseline (Weeks 0-1) and Weeks 11-12.
Change in 8-item Patient Health Questionnaire score from baseline (Weeks 0-1) at Weeks 19-20.
The 8-item Patient Health Questionnaire (PHQ-8) is a self-report measure of depression, which produces a score ranging between 0 and 24. A higher score indicates a greater level of depression symptoms.
Measured: Baseline (Weeks 0-1) and Weeks 19-20
Change in Brief Sussex-Oxford Compassion for Others Scale score from baseline (Weeks 0-1) at Weeks 11-12.
The Brief Sussex-Oxford Compassion for Others Scale (SOCS-O) is a 5-item, self-report measure of compassion for others, which produces a score ranging between 5 and 25. A higher score indicates greater compassion for others.
Measured: Baseline (Weeks 0-1) and Weeks 11-12.
Change in Brief Sussex-Oxford Compassion for Others Scale score from baseline (Weeks 0-1) at Weeks 19-20.
The Brief Sussex-Oxford Compassion for Others Scale (SOCS-O) is a 5-item, self-report measure of compassion for others, which produces a score ranging between 5 and 25. A higher score indicates greater compassion for others.
Measured: Baseline (Weeks 0-1) and Weeks 19-20
Change in Short Warwick-Edinburgh Mental Wellbeing Scale score from baseline (Weeks 0-1) at Weeks 11-12.
The Short Warwick-Edinburgh Mental Wellbeing Scale (SWEMWBS) is a 7-item self-report measure of mental wellbeing, which produces a score ranging between 7 and 35. A higher score indicates a greater level of mental wellbeing.
Measured: Baseline (Weeks 0-1) and Weeks 11-12.
Change in Short Warwick-Edinburgh Mental Wellbeing Scale score from baseline (Weeks 0-1) at Weeks 19-20.
The Short Warwick-Edinburgh Mental Wellbeing Scale (SWEMWBS) is a 7-item self-report measure of mental wellbeing, which produces a score ranging between 7 and 35. A higher score indicates a greater level of mental wellbeing.
Measured: Baseline (Weeks 0-1) and Weeks 19-20.
Change in Sussex Burnout Scale score from baseline (Weeks 0-1) at Weeks 11-12.
The Sussex Burnout Scale (SBS) is a 3-item self-report measure of burnout, which produces a score ranging between 3 and 15. A higher score indicates a greater level of burnout.
Measured: Baseline (Weeks 0-1) and Weeks 11-12.
Change in Sussex Burnout Scale score from baseline (Weeks 0-1) at Weeks 19-20.
The Sussex Burnout Scale (SBS) is a 3-item self-report measure of burnout, which produces a score ranging between 3 and 15. A higher score indicates a greater level of burnout.
Measured: Baseline (Weeks 0-1) and Weeks 19-20.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 May 2026
- Study start13 May 2026
- Primary completionMar 2027 (estimated)
- Study completionMay 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Occupational Stress or Workplace StressStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 186 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Canterbury Christ Church University
- Sponsor type
- University, hospital or other
- Collaborators
- Sussex Partnership NHS Foundation Trust
- Responsible party
- Sponsor
- Investigators
- Fergal W Jones, PhD, PsychD, Principal investigator, Canterbury Christ Church University & Sussex Partnership NHS Foundation TrustClara Strauss, PhD, DClinPsychol, Study chair, Sussex Partnership NHS Foundation Trust & University of SussexBecky Pearse, BA, MSc, Study director, Canterbury Christ Church University & Surrey and Borders Partnership NHS Foundation TrustBecky Pfaff, BSc, MSc, Study director, Canterbury Christ Church University & Surrey and Borders Partnership NHS Foundation TrustLila Maleviti, BSc, MSc, Study director, Canterbury Christ Church University & Surrey and Borders Partnership NHS Foundation Trust
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07560371
- Sponsor's protocol ID
- ETH2526-0057
- Other IDs
- IRAS 366211
- Acronym
- MBCRCT
- Status last verified
- May 2026
- First submitted
- 24 Apr 2026
- Last updated
- 3 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: All outcome measure IPD will be made publicly available. Some or all demographic IPD may be excluded to prevent jigsaw identification of participants. An assessmment of what, if any, demographic IPD can be included will be made once the data have been collected and the risk of participant identification assessed.
Study at a glance
From the registry record, last updated by the sponsor on 3 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Randomized Controlled Trial of an 8-Week Mindfulness "Booster" Course for Staff: Examining Effectiveness, Mediators of Impact, and Participant Experiences
- ClinicalTrials.gov ID
- NCT07560371
- Acronym / sponsor ID
- MBCRCT / ETH2526-0057
- Conditions
- Occupational Stress or Workplace Stress
- Keywords
- booster course, mindfulness, health personnel, perceived stress, health care workers
- Study type
- Interventional
- Recruitment status
- Enrolling by invitation
- Enrolment
- 186 participants (estimated)
- Lead sponsor
- Canterbury Christ Church UniversityUniversity, hospital or other
- Collaborators
- Sussex Partnership NHS Foundation Trust
- Study start
- 13 May 2026 (actual)
- Primary completion
- Mar 2027 (estimated)
- Study completion
- May 2027 (estimated)
- First posted
- 1 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to learn if a mindfulness booster course can reduce stress in healthcare staff who have previously attended a mindfulness course. The main questions it aims to answer are:
- Is a mindfulness booster course for healthcare staff effective at reducing their stress levels?
- Are any benefits maintained for 8 weeks?
Researchers will compare a mindfulness booster course with usual care to see if it helps to reduce stress. Participants will take part in either a mindfulness booster course or do what they usually do to look after their wellbeing. They will complete questionnaires at the beginning, middle and end of the study.
Detailed description
Aims:
- To determine whether the mindfulness booster course for healthcare staff is effective in terms of the primary outcome (perceived stress) and secondary outcomes (wellbeing, depression, burnout, and compassion for others), and whether any benefits are maintained at follow-up.
- To examine whether any effects on the above-mentioned outcomes are statistically mediated by changes in amount of mindfulness practice, rumination and worry, decentering, self-compassion, and trait mindfulness.
- To develop an abbreviated grounded theory of the therapeutic process and outcomes of the mindfulness booster course.
Hypotheses:
- a) The primary hypothesis is that we will see a significantly greater decrease in the primary outcome of perceived stress at post-intervention (the primary time-point of Weeks 11-12) relative to baseline (Weeks 0-1) for the 'mindfulness-booster course plus treatment as usual (TAU)' intervention group compared to the 'TAU-only' control group.
- Our secondary hypothesis is that we will see significantly greater improvements in each of our secondary outcome measures at post-intervention (Weeks 11-12) relative to baseline for our intervention group compared to our control group. Improvements entail decreases in depression and burnout and increases in compassion for others and wellbeing.
- Our third hypothesis is that we will also see the effects detailed in (1a) and (1b) above at the follow-up time-point (Weeks 19-20).
- a) The relationship between group allocation (intervention vs. control) and reduction in perceived stress, from baseline to follow-up (Weeks 19-20), will be statistically mediated by changes from baseline to post-intervention in the following psychological constructs: i) increase in amount of mindfulness practice, both formal and informal; ii) reduction in rumination and worry, i.e., repetitive negative thinking; iii) increase in decentering; iv) increase in self-compassion; v) increase in trait mindfulness.
- The relationships specified in Hypothesis 2a will also hold true for the secondary outcomes (i.e. change from baseline to follow-up [Weeks 19-20] in wellbeing, depression, burnout and compassion for others).
- i) The relationship between group allocation and reduction in perceived stress will be serially statistically as follows: intervention group allocation predicts increased mindfulness practice (from baseline to post-intervention [Weeks 11-12]) which in turn predicts change in psychological mechanisms (i.e., rumination/worry, decentering, self-compassion and trait mindfulness; from baseline to post-intervention [Weeks 11-12]), which in turn predict reduced perceived stress (from baseline to follow-up [Weeks 19-20]). ii) The relationships specified in Hypothesis 2c-i will also hold for the secondary outcomes (i.e. change from baseline to follow-up [Weeks 19-20] in wellbeing, depression, burnout and compassion for others). Design Information Not Included Elsewhere in this Registration: After Weeks 11-12, a subsample of intervention group participants will be invited to participate in a semi-structured individual interview, with the qualitative data being collected and analysed according to grounded theory principles. This aspect of the study has the following sub-aims:
- To explore what processes occur during the mindfulness booster course, based on participants' experiences.
- To explore how these processes interact with the participants' contexts, including, but not limited to, working in healthcare.
- To explore how these processes and contexts interact with, and perhaps drive, any perceived impacts and outcomes of the course.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Mindfulness Booster Course | Experimental | Behavioral: Mindfulness Booster Course, Behavioral: Usual Care |
| Treatment as usual control | Other | Behavioral: Usual Care |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- UK National Health Service staff member.
- Has completed an 8-week mindfulness course (either MBCT, MBCT-L or MBSR). Individuals will be considered to have "completed" a mindfulness course if they attended four or more sessions.
- Is able to make one of the planned sets of times for the booster course sessions, in case they are randomly allocated to the intervention arm.
Key exclusion criteria (4 listed)
- Currently on sick leave.
- Planning on undertaking another 8-week mindfulness course.
- Previously participated in the mindfulness booster course in the feasibility study.
- Have previously found practising mindfulness distressing.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Mindfulness Booster CourseThe mindfulness booster course will consist of eight 30-minute sessions, which participants will be asked to commit to. These will be online and usually occur weekly. Within these sessions, there will be a 15-minute mindfulness practice followed by a 15-minute discussion. This discussion time will involve reflecting on the mindfulness practice and speaking about between-session practice. Participants will be encouraged to practice mindfulness for home work between the sessions. | Behavioural | Mindfulness Booster Course |
| Usual CareParticipants will be encouraged to continue with whatever activities they usually undertake to manage their stress and support their wellbeing. | Behavioural | Mindfulness Booster Course, Treatment as usual control |
Primary outcome
Change in Perceived Stress Scale score from baseline (Weeks 0-1) at Weeks 11-12.
Time frame: Baseline (Weeks 0-1) and Weeks 11-12
The 10-item Perceived Stress Scale (PSS-10) is a self-report measure of perceived stress, which produces a score ranging between 0 and 40. A higher score indicates greater perceived stress.
9 secondary outcomes
Change in Perceived Stress Scale score from baseline (Weeks 0-1) at Weeks 19-20.
Time frame: Baseline (Weeks 0-1) and Weeks 19-20
Change in 8-item Patient Health Questionnaire score from baseline (Weeks 0-1) at Weeks 11-12.
Time frame: Baseline (Weeks 0-1) and Weeks 11-12.
Change in 8-item Patient Health Questionnaire score from baseline (Weeks 0-1) at Weeks 19-20.
Time frame: Baseline (Weeks 0-1) and Weeks 19-20
Change in Brief Sussex-Oxford Compassion for Others Scale score from baseline (Weeks 0-1) at Weeks 11-12.
Time frame: Baseline (Weeks 0-1) and Weeks 11-12.
Change in Brief Sussex-Oxford Compassion for Others Scale score from baseline (Weeks 0-1) at Weeks 19-20.
Time frame: Baseline (Weeks 0-1) and Weeks 19-20
Change in Short Warwick-Edinburgh Mental Wellbeing Scale score from baseline (Weeks 0-1) at Weeks 11-12.
Time frame: Baseline (Weeks 0-1) and Weeks 11-12.
Change in Short Warwick-Edinburgh Mental Wellbeing Scale score from baseline (Weeks 0-1) at Weeks 19-20.
Time frame: Baseline (Weeks 0-1) and Weeks 19-20.
Change in Sussex Burnout Scale score from baseline (Weeks 0-1) at Weeks 11-12.
Time frame: Baseline (Weeks 0-1) and Weeks 11-12.
Change in Sussex Burnout Scale score from baseline (Weeks 0-1) at Weeks 19-20.
Time frame: Baseline (Weeks 0-1) and Weeks 19-20.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Jun 2026.
- Individual participant dataSharing planned: Yes. All outcome measure IPD will be made publicly available. Some or all demographic IPD may be excluded to prevent jigsaw identification of participants. An assessmment of what, if any, demographic IPD can be included will be made once the data have been collected and the risk of participant identification assessed.
Related trials for Occupational Stress or Workplace Stress
Active, not recruiting
Online Mindfulness-Based Stress Reduction for the Mental Health of Healthcare Professionals
Occupational Stress or Workplace Stress, Burnout, Professionals
Not yet recruiting
Feasibility of Body Acupuncture for Stress, Burnout, Sleep Quality and Wellbeing: A Pilot Study
Occupational Stress or Workplace Stress, Exhaustion, Caregiver
Not yet recruiting
Effect of Agarwood (Aquilaria Sinensis) Inhalation Aromatherapy on Workplace Fatigue and Sleep Quality Among Hospital Employees: A Randomized Controlled Trial
Fatigue, Occupational Stress or Workplace Stress
Recruiting
Stress and Musculoskeletal Health in Employees
Musculoskeletal Diseases or Conditions, Musculoskeletal Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Fergal W Jones, PhD, PsychD principal investigator
Canterbury Christ Church University & Sussex Partnership NHS Foundation Trust
Clara Strauss, PhD, DClinPsychol study chair
Sussex Partnership NHS Foundation Trust & University of Sussex
Becky Pearse, BA, MSc study director
Canterbury Christ Church University & Surrey and Borders Partnership NHS Foundation Trust
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Mindfulness Booster Course in people with Occupational Stress or Workplace Stress, run by Canterbury Christ Church University at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: enrolling by invitation, as of the sponsor's last update on 3 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Perceived Stress Scale score from baseline (Weeks 0-1) at Weeks 11-12. (time frame: Baseline (Weeks 0-1) and Weeks 11-12). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jun 2026.